| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $127.1M-6.3% | $135.6M-1.6% | $137.9M-3.4% | $142.8M+13.4% | $125.9M |
| General and administrative expense, exclusive of depreciation expense shown below | $45.4M+14.2% | $39.8M-1.2% | $40.3M+5.6% | $38.1M-13.7% | $44.2M |
| Depreciation | $14.3M-1.1% | $14.4M-5.5% | $15.3M-7.2% | $16.5M-7.2% | $17.8M |
| Amortization | $359K-28.8% | $504K+2.9% | $490K-28.5% | $685K-10.1% | $762K |
| Other (income) expense, net | -$7.6M+23.5% | -$10.0M-1070.9% | -$850K-17.7% | -$722K+87.1% | -$5.6M |
| OPERATING INCOME | $56.5M-3.6% | $58.6M+7.2% | $54.6M+31.6% | $41.5M-8.3% | $45.3M |
| Interest expense | $10.6M-14.5% | $12.4M-7.9% | $13.4M+16.1% | $11.6M+26.4% | $9.2M |
| Income before income taxes | $45.9M-0.6% | $46.2M+12.1% | $41.2M+37.6% | $30.0M-17.0% | $36.1M |
| Income tax expense | $15.5M+10.5% | $14.0M+235.3% | $4.2M-59.4% | $10.3M-35.2% | $15.9M |
| Net income | $30.4M-5.5% | $32.2M-13.2% | $37.0M+88.3% | $19.7M-2.8% | $20.2M |
| Net income attributable to non-controlling interest | $722K-4.1% | $753K+115.1% | $350K+70.7% | $205K-58.3% | $492K |
| Net income attributable to Core Laboratories Inc. | $29.7M-5.5% | $31.4M-14.4% | $36.7M+88.5% | $19.5M-1.4% | $19.7M |
| Basic earnings per share | $650.00-5.8% | $690.00-12.7% | $790.00+88.1% | $420.00-4.5% | $440.00 |
| Basic earnings per share attributable to Core Laboratories Inc. | $640.00-4.5% | $670.00-15.2% | $790.00+88.1% | $420.00-2.3% | $430.00 |
| Diluted earnings per share | $650.00-3.0% | $670.00-14.1% | $780.00+85.7% | $420.00-2.3% | $430.00 |
| Diluted earnings per share attributable to Core Laboratories Inc. | $630.00-4.5% | $660.00-14.3% | $770.00+83.3% | $420.00+0.0% | $420.00 |
| Basic | $46.4M-1.0% | $46.9M+0.5% | $46.7M+0.8% | $46.3M+0.7% | $46.0M |
| Diluted | $47.0M-1.4% | $47.7M+0.3% | $47.5M+1.5% | $46.8M+0.3% | $46.7M |
| Service [Member] | |||||
| Cost of services and product sales exclusive of depreciation expense shown below | $115.4M-6.3% | $123.2M+4.6% | $117.8M-1.3% | $119.4M+19.1% | $100.3M |
| Product [Member] | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.